首页> 外文期刊>Biological chemistry >Glutathione dysregulation and the etiology and progression of human diseases.
【24h】

Glutathione dysregulation and the etiology and progression of human diseases.

机译:谷胱甘肽功能失调以及人类疾病的病因和进展。

获取原文
获取原文并翻译 | 示例
       

摘要

Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and as a result, disturbances in GSH homeostasis are implicated in the etiology and/or progression of a number of human diseases, including cancer, diseases of aging, cystic fibrosis, and cardiovascular, inflammatory, immune, metabolic, and neurodegenerative diseases. Owing to the pleiotropic effects of GSH on cell functions, it has been quite difficult to define the role of GSH in the onset and/or the expression of human diseases, although significant progress is being made. GSH levels, turnover rates, and/or oxidation state can be compromised by inherited or acquired defects in the enzymes, transporters, signaling molecules, or transcription factors that are involved in its homeostasis, or from exposure to reactive chemicals or metabolic intermediates. GSH deficiency or a decrease in the GSH/glutathione disulfide ratio manifests itself largely through an increased susceptibility to oxidative stress, and the resulting damage is thought to be involved in diseases, such as cancer, Parkinson's disease, and Alzheimer's disease. In addition, imbalances in GSH levels affect immune system function, and are thought to play a role in the aging process. Just as low intracellular GSH levels decrease cellular antioxidant capacity, elevated GSH levels generally increase antioxidant capacity and resistance to oxidative stress, and this is observed in many cancer cells. The higher GSH levels in some tumor cells are also typically associated with higher levels of GSH-related enzymes and transporters. Although neither the mechanism nor the implications of these changes are well defined, the high GSH content makes cancer cells chemoresistant, which is a major factor that limits drug treatment. The present report highlights and integrates the growing connections between imbalances in GSH homeostasis and a multitude of human diseases.
机译:谷胱甘肽(GSH)在包括细胞分化,增殖和凋亡在内的多种细胞过程中起着重要作用,其结果是,GSH稳态的紊乱与许多人类疾病的病因和/或进展有关,包括癌症,衰老,囊性纤维化以及心血管,炎症,免疫,代谢和神经退行性疾病。由于谷胱甘肽对细胞功能的多效性作用,尽管正在取得重大进展,但是很难确定谷胱甘肽过氧化物在人类疾病的发作和/或表达中的作用。 GSH水平,周转率和/或氧化状态可能因其稳态中涉及的酶,转运蛋白,信号分子或转录因子的遗传或获得性缺陷,或由于暴露于反应性化学物质或代谢中间体而受到损害。谷胱甘肽缺乏症或谷胱甘肽/谷胱甘肽二硫化物比率的降低主要通过对氧化应激的敏感性增加而表现出来,并且所造成的损害被认为与疾病有关,例如癌症,帕金森氏病和阿尔茨海默氏病。另外,谷胱甘肽水平的失衡会影响免疫系统功能,并被认为在衰老过程中起作用。正如低的细胞内GSH水平会降低细胞的抗氧化能力一样,升高的GSH水平通常会增加抗氧化能力和对氧化应激的抵抗力,这在许多癌细胞中都可以观察到。一些肿瘤细胞中较高的GSH水平通常也与较高的GSH相关酶和转运蛋白水平相关。尽管这些变化的机制和含义均未明确,但高GSH含量使癌细胞具有化学抗性,这是限制药物治疗的主要因素。本报告强调并综合了GSH体内稳态失衡与多种人类疾病之间日益增长的联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号